Andere Kunden interessierten sich auch für
![Particulate Interactions in Dry Powder Formulation for Inhalation]( "Particulate Interactions in Dry Powder Formulation for Inhalation")
Particulate Interactions in Dry Powder Formulation for Inhalation85,99 €![Pharmaceutical Powder Compaction Technology]( "Pharmaceutical Powder Compaction Technology")
Pharmaceutical Powder Compaction Technology77,99 €![Liposome Technology]( "Liposome Technology")
Liposome Technology89,99 €![Microbial Contamination Control in the Pharmaceutical Industry]( "Microbial Contamination Control in the Pharmaceutical Industry")
Microbial Contamination Control in the Pharmaceutical Industry85,99 €![Good Pharmaceutical Manufacturing Practice]( "Good Pharmaceutical Manufacturing Practice")
Good Pharmaceutical Manufacturing Practice85,99 €![Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics]( "Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics")
Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics85,99 €![Pharmaceutical Engineering Change Control]( "Pharmaceutical Engineering Change Control")
Pharmaceutical Engineering Change Control85,99 €
Due to a worldwide need for lower cost drug therapy, use of generic and multi-source drug products have been increasing. To meet international patent and trade agreements, the development and sale of these products must conform to national and international laws, and generic products must prove that they are of the same quality and are therapeutically equivalent to the brand name alternative. However, many countries have limited resources to inspect and verify the quality of all drug products for sale in their country. This title discusses the worldwide legislative and regulatory requirements for the registration of generic and multi-source drug products.